The proposed UW CFAR is organized around 6 core units: Administration (including information transfer/publications and research training); clinical and molecular retrovirology; immunology, clinical research; biostatistics and epidemiology (including International AIDS Research and AIDS Registry); and non- human primate research. Two additional core units, behavioral sciences research and radiological imaging research, are envisioned via separate funding in future years. Over 75 faculty staff investigators of the proposed CFAR participate in active or pending research grants directly related to AIDS, HIV, or SIV and many of these also have other active grants in closely related fields such as non-primate retrovirology, molecular/cellular immunology, and other STDs. Ten distinct AIDS related themes have been identified, many involving parallel research in humans and non-human primates. The proposed CFAR would help coordinate this research to ensure efficient use of primates in research most relevant to human infection. Six active and two pending institutional post-doctoral research or clinical training grants at the UW are AIDS related. The process of planning this proposal has helped to coordinate the new allocations of 7450 sq. ft. of lab space to basic research on HIV and SIV. The CFAR would fund alteration, renovation, and equipping of a portion of these labs on the UW campus and at Fred Hutchinson Cancer Research Center. Planning for relocation of the HMC AIDS Clinic and the NIAID ACTU is already funded and underway. The CFAR would fund creation and co-location of a CFAR Clinical Research unit, including clinical and epidemiologic research trainees at the same site as the AIDS clinic and ACTU.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
3P30AI027757-05S1
Application #
3101062
Study Section
Special Emphasis Panel (SRC (41))
Project Start
1988-09-30
Project End
1994-02-28
Budget Start
1992-09-01
Budget End
1994-02-28
Support Year
5
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Hamilton, Deven T; Goodreau, Steven M; Jenness, Samuel M et al. (2018) Potential Impact of HIV Preexposure Prophylaxis Among Black and White Adolescent Sexual Minority Males. Am J Public Health 108:S284-S291
Bilal, Usama; McCaul, Mary E; Crane, Heidi M et al. (2018) Predictors of Longitudinal Trajectories of Alcohol Consumption in People with HIV. Alcohol Clin Exp Res 42:561-570
Morgan, Ethan; Skaathun, Britt; Duvoisin, Rebeccah et al. (2018) Are HIV Seroconversions Among Young Men Who Have Sex With Men Associated With Social Network Proximity to Recently or Long-Term HIV-Infected Individuals? J Acquir Immune Defic Syndr 77:128-134
Wagner, Anjuli D; Njuguna, Irene N; Neary, Jillian et al. (2018) Financial Incentives to Increase Uptake of Pediatric HIV Testing (FIT): study protocol for a randomised controlled trial in Kenya. BMJ Open 8:e024310
Beima-Sofie, Kristin; Wamalwa, Dalton; Maleche-Obimbo, Elizabeth et al. (2018) Toll-like receptor 9 polymorphism is associated with increased Epstein-Barr virus and Cytomegalovirus acquisition in HIV-exposed infants. AIDS 32:267-270
Balkus, Jennifer E; Brown, Elizabeth R; Palanee-Phillips, Thesla et al. (2018) Performance of a Validated Risk Score to Predict HIV-1 Acquisition Among African Women Participating in a Trial of the Dapivirine Vaginal Ring. J Acquir Immune Defic Syndr 77:e8-e10
AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord (2018) Non-Hodgkin lymphoma risk in adults living with HIV across five continents. AIDS 32:2777-2786
Morgan, Ethan; Skaathun, Britt; Schneider, John A (2018) Sexual, Social, and Genetic Network Overlap: A Socio-Molecular Approach Toward Public Health Intervention of HIV. Am J Public Health 108:1528-1534
Fredericksen, R J; Gibbons, L; Brown, S et al. (2018) Medication understanding among patients living with multiple chronic conditions: Implications for patient-reported measures of adherence. Res Social Adm Pharm 14:540-544
Liu, Amy Y; De Rosa, Stephen C; Guthrie, Brandon L et al. (2018) High background in ELISpot assays is associated with elevated levels of immune activation in HIV-1-seronegative individuals in Nairobi. Immun Inflamm Dis 6:392-401

Showing the most recent 10 out of 1275 publications